Highlands Oncology Group PA — Fayetteville, Arkansas

Highlands Oncology Group PA is a clinical research site located in Fayetteville, Arkansas, United States 72703.

Crixeo Clinical Trials Trust Score: 20/100 (FAILING). This profile has not yet been claimed by the site owner.

Highlands Oncology Group PA has participated in 14 clinical trials with 10 currently active.

Therapeutic areas: Melanoma, Non-small Cell Lung Cancer, Squamous Cell Carcinoma of the Head and Neck.

Sponsors: Seagen, a wholly owned subsidiary of Pfizer, Pfizer, Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Fayetteville

Browse all research sites in Arkansas · View every site in Fayetteville

Sponsor Feasibility Report

Trust Score: 20/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Highlands Oncology Group PA?

Highlands Oncology Group PA has a Crixeo Trust Score of 20/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Highlands Oncology Group PA conducted?

Highlands Oncology Group PA has 14 clinical trials on record, with 10 currently active. Their work covers Melanoma, Non-small Cell Lung Cancer, Squamous Cell Carcinoma of the Head and Neck.

Is Highlands Oncology Group PA accredited by Crixeo Clinical Trials?

Highlands Oncology Group PA has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Highlands Oncology Group PA?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.